{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:27:49Z","timestamp":1793852869101,"version":"4.6.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jclinepi.2026.112458","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:45:21Z","timestamp":1786491921000},"page":"112458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The erosion of proof in paradigm transitions: the rise of narrative rationality in health technology assessment"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9398-2968","authenticated-orcid":false,"given":"Jean-Christophe","family":"Lega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Gougeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudina","family":"Michal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steeve","family":"Provencher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Naudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Falissard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Chevret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remy","family":"Boussageon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2026.112458_bib1","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMp1210007","article-title":"Reform, regulation, and pharmaceuticals \u2014 the Kefauver\u2013Harris amendments at 50","volume":"367","author":"Greene","year":"2012","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jclinepi.2026.112458_bib5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jval.2013.04.011","article-title":"Performance-Based risk-sharing Arrangements\u2014Good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task force","volume":"16","author":"Garrison","year":"2013","journal-title":"Value in Health"},{"key":"10.1016\/j.jclinepi.2026.112458_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-083866","article-title":"Core GRADE 6: presenting the evidence in summary of findings tables","volume":"389","author":"Guyatt","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2026.112458_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.therap.2022.10.008","article-title":"Project rebuild the evidence base (REB): a method to interpret randomised clinical trials and their meta-analysis to present solid benefit-risk assessments to patients","volume":"78","author":"Boussageon","year":"2023","journal-title":"Therapie"},{"key":"10.1016\/j.jclinepi.2026.112458_bib8","series-title":"The logic of scientific discovery","author":"Popper","year":"1959"},{"key":"10.1016\/j.jclinepi.2026.112458_bib9","series-title":"Introduction \u00e0 l\u2019\u00e9tude de la m\u00e9decine exp\u00e9rimentale","author":"Bernard","year":"1865"},{"key":"10.1016\/j.jclinepi.2026.112458_bib10","series-title":"The design of experiments","author":"Fisher","year":"1935"},{"key":"10.1016\/j.jclinepi.2026.112458_bib11","first-page":"289","article-title":"IX. On the problem of the most efficient tests of statistical hypotheses","volume":"231","author":"Neyman","year":"1933","journal-title":"Philos Trans A Math Phys Eng Sci"},{"key":"10.1016\/j.jclinepi.2026.112458_bib12","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1191\/1740774505cn097oa","article-title":"How FDA currently makes decisions on clinical studies","volume":"2","author":"Temple","year":"2005","journal-title":"Clin Trials"},{"key":"10.1016\/j.jclinepi.2026.112458_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0193841X241229106","article-title":"The alternative factors leading to replication crisis: prediction and evaluation","volume":"49","author":"Chernov","year":"2025","journal-title":"Eval Rev"},{"key":"10.1016\/j.jclinepi.2026.112458_bib15","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1001\/jama.1987.03390180077027","article-title":"Are all significant P values created equal? The analogy between diagnostic tests and clinical research","volume":"257","author":"Browner","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.jclinepi.2026.112458_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nbt.2786","article-title":"Clinical development success rates for investigational drugs","volume":"32","author":"Hay","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jclinepi.2026.112458_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2026.112341","article-title":"Changes in estimands and prevalence of discrepancies in conclusions under the two-trial paradigm: a systematic review","volume":"196","author":"Hlavaty","year":"2026","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2026.112458_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3284","article-title":"Assessment of clinical trials supporting US food and drug administration approval of novel therapeutic agents, 1995-2017","volume":"3","author":"Zhang","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jclinepi.2026.112458_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2022.810315","article-title":"Solving the evidence interpretability crisis in health technology assessment: a role for mechanistic models?","volume":"4","author":"Courcelles","year":"2022","journal-title":"Front Med Technol"},{"key":"10.1016\/j.jclinepi.2026.112458_bib20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(04)17670-8","article-title":"External validity of randomised controlled trials: \u201cto whom do the results of this trial apply?\u201d","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jclinepi.2026.112458_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094207","article-title":"The influence of the patient-clinician relationship on healthcare outcomes: a systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Kelley","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jclinepi.2026.112458_bib23","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMp2306872","article-title":"The Accelerated Approval Program for cancer drugs \u2014 finding the right balance","volume":"389","author":"Gyawali","year":"2023","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jclinepi.2026.112458_bib24","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1164\/rccm.202109-2121LE","article-title":"Major decrease in lung transplantation for patients with cystic fibrosis in France","volume":"205","author":"Martin","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jclinepi.2026.112458_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020124","article-title":"Why Most published research findings are false","volume":"2","author":"Ioannidis","year":"2005","journal-title":"PLOS Med"},{"key":"10.1016\/j.jclinepi.2026.112458_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2680","article-title":"How citation distortions create unfounded authority: analysis of a citation network","volume":"339","author":"Greenberg","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2026.112458_bib30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/0272989X17725740","article-title":"Methods for population-adjusted indirect comparisons in health technology appraisal","volume":"38","author":"Phillippo","year":"2018","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jclinepi.2026.112458_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjebm-2025-113995","article-title":"Ataluren for Duchenne: how politics and social pressure undermined evidence-based decisions","author":"Erviti","year":"2025","journal-title":"BMJ Evid Based Med"},{"key":"10.1016\/j.jclinepi.2026.112458_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2023.0217","article-title":"Timing of confirmatory trials for drugs granted accelerated approval based on surrogate measures from 2012 to 2021","volume":"4","author":"Deshmukh","year":"2023","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.jclinepi.2026.112458_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10654-017-0230-6","article-title":"For and against methodologies: some perspectives on recent causal and statistical inference debates","volume":"32","author":"Greenland","year":"2017","journal-title":"Eur J Epidemiol"},{"issue":"8","key":"10.1016\/j.jclinepi.2026.112458_bib34","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1108\/JHOM-08-2020-0344","article-title":"Consumer perspectives of accelerated access to medicines: a qualitative study","volume":"35","author":"Pace","year":"2021","journal-title":"J Health Organ Manag"},{"key":"10.1016\/j.jclinepi.2026.112458_bib35","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using big data to emulate a target trial when a randomized trial is not available","volume":"183","author":"Hern\u00e1n","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jclinepi.2026.112458_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2025-086810","article-title":"Concordance between target trial emulation and randomised controlled trials: systematic review and meta-analysis","volume":"393","author":"Wang","year":"2026","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2026.112458_bib37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1017\/S0266462319000333","article-title":"Population adjustment methods for indirect comparisons: a review of National Institute for Health and Care Excellence Technology appraisals","volume":"35","author":"Phillippo","year":"2019","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.jclinepi.2026.112458_bib38","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/cpt.2954","article-title":"Physician perspectives on the Food and Drug Administration \u2019s decision to grant accelerated approval to aducanumab for alzheimer\u2019s disease","volume":"114","author":"Dhruva","year":"2023","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1016\/j.jclinepi.2026.112458_bib40","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1017\/S0266462323000818","article-title":"OP47 the risk-based price: incorporating uncertainty and risk attitudes in health technology pricing","volume":"39","author":"Kirwin","year":"2023","journal-title":"Int J Technol Assess Health Care"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435626003343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435626003343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:07:31Z","timestamp":1793851651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435626003343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":31,"alternative-id":["S0895435626003343"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2026.112458","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The erosion of proof in paradigm transitions: the rise of narrative rationality in health technology assessment","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2026.112458","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112458"}}